2X Match My Gift
This National Cancer Survivors Month, your gift is matched to expand treatment options and bring more patients into survivorship through Project Cure CRC.

Robotic-assisted surgery (also called robotic surgery) is a type of minimally invasive surgery.
Robotic surgery allows doctors to perform complex procedures with more precision, flexibility, and control than is possible with the human hand.
Instead of a large incision, the surgeon makes a few very small incisions (about ¼ to ½ inch) into the abdomen to insert the small “arms” of the robot. A slightly larger incision, about two inches wide, is made to remove the tumor.

Advantages to robotic-assisted surgery are similar to those of laparoscopic surgery.
They include:

Many colorectal cancer patients are good candidates for robotic-assisted colectomy surgery.
The best option for you depends on several factors, including:

Learn more about how robotic-assisted surgery is used for colorectal surgery in this helpful video.

While these two methods are similar, there are some differences:
Laparoscopic surgery is performed by hand, with the help of a two-dimensional camera.
Robotic-assisted surgery requires the surgeon to operate instruments from outside the patient’s body, using aconsole and a three-dimensional camera.

For many cancer patients, the end of active treatment brings a new kind of dread. Scans every few months and anxious waits for results. A blood test is changing that experience for a growing number of patients.

When Helen was diagnosed with metastatic colorectal cancer, the biggest concern for her medical team was that her cancer had spread to her liver. One type of therapy, hepatic artery infusion, offered a path forward, but there was a catch. Nobody at her hospital had ever done it before. She'd have to be first.

hrough Project Cure CRC, the Alliance is fueling bold, early-stage research with the potential to transform colorectal cancer treatment. Dr. Lisa Mielke’s groundbreaking work explores how the gut’s immune system and nerve signaling influence cancer growth—opening the door to new therapeutic approaches, including repurposed existing drugs. This is what’s possible when promising ideas get the support they need to move forward.